Immunoassay Instruments Market

Immunoassay Instruments Market (Product Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments Application Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • Rep Id : TMRGL1635
  • Published On : Aug 2014
  • No. of Pages : 128
  • Category : Healthcare

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
      1.2.1 Sources
              1.2.1.1 Secondary Research
              1.2.1.2 Primary Research
              1.2.1.3 Assumptions
1.3 Market Segmentation
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Comparative Analysis: Global Immunoassay Instruments Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction
      3.1.1 Flow Chart of Immunoassay Development, Optimization and Validation
3.2 Market Potential of Immunoassay Instruments
      3.2.1 Biomarker Discovery Process
3.3 Future Scenario of Immunoassay Instruments Market
3.4 Event Impact Analysis
3.5 Market Dynamics
3.6 Market Drivers
      3.6.1 Rising incidence of chronic infectious diseases will drive the immunoassay instruments market
      3.6.2 Rate of HIV Infections by World Regions, (2001-2012)
      3.6.3 Technological advances coupled with enhanced discovery of specific biomarkers will drive the demand for immunoassay instruments
      3.6.4 Increasing preference for personalized medicine creates a demand for novel and specific immunoassays
3.7 Market Restraints
      3.7.1 High cost associated with technologically advanced immunoassay systems
3.8 Market Opportunities
      3.8.1 Focus on developing compact, portable reliable immunoassay instruments
      3.8.2 Investments in emerging economies
3.9 Value Chain Analysis: Global Immunoassay Instruments Market
3.10 Regulatory and Reimbursement Overview
3.11 Porter’s Five Forces Analysis for the Global Immunoassay Instruments Market
      3.11.1 Bargaining power of suppliers
      3.11.2 Bargaining power of buyers
      3.11.3 Threat of substitutes
      3.11.4 Threat of new entrants
      3.11.5 Competitive rivalry
3.12 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography
3.13 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %)
3.14 Competitive Landscape
      3.14.1 Global Immunoassay Instruments Market Share by Key Players, 2013 (Value %)
 
Chapter 4 Global Immunoassay Instruments Market, by Products
4.1 Overview
      4.1.1 Global Immunoassay Instruments Market Revenue, by Products, 2012 - 2020 (USD Billion)
4.2 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %)
4.3 Chemiluminescence (CLI) Analyzers
      4.3.1 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012- 2020 (USD Billion)
4.4 Immunofluorescence Analyzers (IFA)
      4.4.1 Global Immunofluorescence Analyzers Market Revenue, 2012- 2020 (USD Billion)
4.5 Enzyme Immunoassay Instruments
      4.5.1 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion)
4.6 Radioimmunoassay (RIA) Instruments
      4.6.1 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
4.7 Enzyme Linked Fluorescent Assay (ELFA) Systems
      4.7.1 Global Enzyme Linked Fluorescent Assays (ELFA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
4.8 Multiplexed Assay Systems
      4.8.1 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion)
 
Chapter 5 Global Immunoassay Instruments Market, by Application
5.1 Overview
      5.1.1 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion)
5.2 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2012 – 2020 (Value %)
5.3 Endocrinology
      5.3.1 Global Endocrinology Application Market Revenue, 2012- 2020 (USD Billion)
5.4 Infectious Disease Testing
      5.4.1 Global Infectious Disease Testing Application Market Revenue, 2012- 2020 (USD Billion)
5.5 Oncology
      5.5.1 Global Oncology Application Market Revenue, 2012- 2020 (USD Billion)
5.6 Cardiology
      5.6.1 Global Cardiology Application Market Revenue, 2012- 2020 (USD Billion)
5.7 Therapeutic Drug Monitoring
      5.7.1 Global Therapeutic Drug Monitoring Application Market Revenue, 2012- 2020 (USD Billion)
5.8 Autoimmune Diseases Testing
      5.8.1 Global Autoimmune Diseases Testing Application Market Revenue, 2012- 2020 (USD Billion)
5.9 Drugs of Abuse Testing
      5.9.1 Global Drug Abuse Testing Application Market Revenue, 2012- 2020 (USD Billion)
 
Chapter 6 Global Immunoassay Instruments Market, by Geography
6.1 Overview
      6.1.1 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion)
6.2 North America
      6.2.1 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
6.3 Europe
      6.3.1 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
6.5 Rest of the World (RoW)
      6.5.1 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
 
Chapter 7 Recommendations
7.1 Recommendations
      7.1.1 Enhancing distribution networks
      7.1.2 Improvements in after sale services to hospitals, diagnostic labs and private practitioners
      7.1.3 Expansion in emerging regions such as Asia and Africa
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 bioMerieux, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 DiaSorin S.p.A
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 F. Hoffman-La Roche, Ltd.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Merck Millipore
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Ortho Clinical Diagnostics
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Siemens Healthcare
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Sysmex Corporation
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Thermo Fisher Scientific
       8.10.1 Company Overview
       8.10.2 Financial Overview
       8.10.3 Product Portfolio
       8.10.4 Business Strategies
       8.10.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Immunoassay Instruments Market
TABLE 3 Event Impact Analysis, 2012 – 2020
TABLE 4 Global Immunoassay Instruments Market Revenue, by Products, 2012 – 2020 (USD Billion)
TABLE 5 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion)
TABLE 6 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion)

List of Figures
 
FIG. 1 Immunoassay Instruments Market Segmentation
FIG. 2 Global Immunoassay Instruments Market, by Applications, 2013 (USD Billion)
FIG. 3 Global Immunoassay Instruments Market, by Products, 2013 (USD Billion)
FIG. 4 Comparative Analysis: Global Electrodes for Medical Devices Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Immunoassay Development, Optimization and Validation Process
FIG. 6 Biomarker Discovery Process
FIG. 7 Rate of HIV Infections by World Regions, (2001 – 2012)
FIG. 8 Global Immunoassay Instruments Market Value Chain Analysis
FIG. 9 Porter’s Five Forces Analysis: Global Immunoassay Instruments Market
FIG. 10 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography, 2013
FIG. 11 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %)
FIG. 12 Immunoassay Instruments: Global Market Share by Key Players, 2013 (Value %)
FIG. 13 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %)
FIG. 14 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012 – 2020 (USD Billion)
FIG. 15 Global Immunofluorescence Analyzers Market Revenue, 2012 – 2020 (USD Billion)
FIG. 16 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion)
FIG. 17 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 18 Global ELFA Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 19 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion)
FIG. 20 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2013 & 2020 (Value %)
FIG. 21 Global Endocrinology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 22 Global Infectious Disease Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 23 Global Oncology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 24 Global Cardiology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 25 Global Therapeutic Drug Monitoring Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 26 Global Autoimmune Diseases Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 27 Global Drug Abuse Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 28 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 29 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 30 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 31 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 32 Abbott Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 33 bioMerieux, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 34 DiaSorin, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 35 F. Hoffman-La Roche, Ltd.: Annual Revenue (Group Sales), 2011 – 2013 (USD Million)
FIG. 36 Merck Millipore, Annual Revenue, 2010 – 2012 (USD million)
FIG. 37 Ortho Clinical Diagnostics, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 38 Siemens Healthcare, Annual Revenue (Group Revenue): 2011– 2013 (USD Million)
FIG. 39 Sysmex Corporation, Annual Revenue, 2011 – 2013 (USD Million)
FIG. 40 Thermo Fisher Scientific, Annual Revenue: 2011 – 2013 (USD million)

.